Pegylated recombinant human arginase i bct-100 Uses, Dosage, Side Effects and more
Pegylated recombinant human arginase i bct-100 is under investigation in clinical trial NCT03455140 (A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)).
| Trade Name | Pegylated recombinant human arginase i bct-100 |
| Generic | Pegylated Recombinant Human Arginase I |
| Pegylated Recombinant Human Arginase I Other Names | Pegylated recombinant human arginase i bct-100 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
